Skip to main content
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 1987 Oct;62(10):1005–1008. doi: 10.1136/adc.62.10.1005

Reduced incidence of tuberculosis by prophylactic chemotherapy in subjects showing strong reactions to tuberculin testing.

L P Ormerod 1
PMCID: PMC1778687  PMID: 3674920

Abstract

The introduction of chemoprophylaxis with rifampicin and isoniazid in 1981 significantly reduced the incidence of tuberculosis. Between 1978 and 1981 children accounted for 136 of 642 notified cases, and this was reduced to 55 of 418 between 1982 and 1986. This effect was most obvious among children from the Indian subcontinent who comprised 80.2% of the children treated. The incidence among white children was not affected. Few side effects occurred and only two of 339 (0.6%) later developed clinical tuberculosis. Chemoprophylaxis plays an important part in the management of tuberculosis in a district with a high incidence of the disease.

Full text

PDF
1007

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Efficacy of various durations of isoniazid preventive therapy for tuberculosis: five years of follow-up in the IUAT trial. International Union Against Tuberculosis Committee on Prophylaxis. Bull World Health Organ. 1982;60(4):555–564. [PMC free article] [PubMed] [Google Scholar]
  2. FEREBEE S., MOUNT F. W., ANASTASIADES A. Prophylactic effects of isoniazid on primary tuberculosis in children; a preliminary report. Am Rev Tuberc. 1957 Dec;76(6):942–963. doi: 10.1164/artpd.1957.76.6.942. [DOI] [PubMed] [Google Scholar]
  3. Ferebee S. H. Long-term effects of isoniazid prophylaxis. Bull Int Union Tuberc. 1968 Dec;41:161–166. [PubMed] [Google Scholar]
  4. Gardner P. A., Moss P. D., Stalker R. Tuberculosis and the immigrant in Blackburn. Public Health. 1972 May;86(4):189–197. doi: 10.1016/s0033-3506(72)80017-9. [DOI] [PubMed] [Google Scholar]
  5. Grzybowski S., Ashley M. J., Pinkus G. Chemoprophylaxis in inactive tuberculosis: long-term evaluation of a Canadian trial. Can Med Assoc J. 1976 Apr 3;114(7):607–611. [PMC free article] [PubMed] [Google Scholar]
  6. Horne N. W. Control and prevention of tuberculosis: a code of practice. Thorax. 1984 May;39(5):321–325. doi: 10.1136/thx.39.5.321. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Horwitz O., Magnus K. Epidemiologic evaluation of chemoprophylaxis against tuberculosis. Am J Epidemiol. 1974 May;99(5):333–342. doi: 10.1093/oxfordjournals.aje.a121618. [DOI] [PubMed] [Google Scholar]
  8. Ormerod L. P., Harrison J. M., Wright P. A. Drug resistance in Mycobacterium tuberculosis: a survey over 25 years in Blackburn. Thorax. 1986 Dec;41(12):946–950. doi: 10.1136/thx.41.12.946. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Wales J. M., Buchan A. R., Cookson J. B., Jones D. A., Marshall B. S. Tuberculosis in a primary school: the Uppingham outbreak. Br Med J (Clin Res Ed) 1985 Oct 12;291(6501):1039–1040. doi: 10.1136/bmj.291.6501.1039. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES